Skip to main content

Table 4 Antihypertensive medicine use at baseline and 6-months

From: Improved hypertension control at six months using an adapted WHO HEARTS-based implementation strategy at a large urban HIV clinic in Uganda

Categories

Baseline (N = 1015)

Six-months

Controlled (N = 752)

Not Controlled (N = 248)

# of antihypertensive medicines

 0

976 (96.2%)

-

-

 1

39 (3.8%)

163 (21%)

12 (5%)

  >  = 2

-

587 (79%)

236 (95%)

Protocol medicines and daily dose

 Amlodipine 5 mg

28

533 (90%)

61 (10%)

 Amlodipine 10 mg

11

216 (54%)

182 (46%)

 Valsartan 80 mg

-

569 (79%)

149 (21%)

 Valsartan 160 mg

-

21 (19%)

88 (81%)

 Hydrochlorothiazide 12.5 mg

-

-

-

Medicine combination by Protocol step

 Step 1. Amlodipine 5 mg

-

151 (20%)

6 (2%)

 Step 2. Amlodipine 5 mg + Valsartan 80 mg

-

381 (50%)

55 (22%)

 Step 3. Amlodipine 10 mg + Valsartan 80 mg

-

186 (25%)

93 (38%)

 Step 4. Amlodipine 10 mg + Valsartan 160 mg

-

20 (3%)

88 (35%)

 Step 5. Amlodipine 10 mg + Valsataran  160 mg + Hydrochlorothiazide 12.5 mg

-

-

-

 Other

-

12 (2%)

6 (2%)

  1. Data for 15 patients was not complete at six months